Diligence memo · auto-generated · as of July 2, 2026
Interpace Diagnostics Group, Inc.
Interpace Diagnostics Group, Inc. has raised $113M over 5 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Interpace Diagnostics Group, Inc. operates in Medical Devices, based in PARSIPPANY.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Interpace Diagnostics Group, Inc. has raised $113M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $47M on 2020-01-10.
Most recent recorded round closed around 2024-10-11.
Valuation (modeled)modeled
Provath models Interpace Diagnostics Group, Inc. at approximately $365M (range $164M–$534M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 23 months.
Last raise 21 mo ago; this sector typically re-raises about every 16 months.
Slightly overdue versus sector cadence.
The last round stepped up 1.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 98% of Medical Devices peers (233 compared).
Modeled value ranks above 95% of those peers.
Closest niche peers: Digital Diagnostics Inc., Redcliffe Lifetech Inc, ACTIV Surgical, Inc..
Peoplefiled
18 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.